The chlamydia screening studies: rationale and design

被引:40
|
作者
Low, N
McCarthy, A
Macleod, J
Salisbury, C
Horner, PJ
Roberts, TE
Campbell, R
Herring, A
Skidmore, S
Sanford, E
Sterne, JAC
Smith, GD
Graham, A
Huengsberg, M
Ross, J
Egger, M
机构
[1] Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England
[2] Univ Birmingham, Dept Primary Care, Birmingham B15 2TT, W Midlands, England
[3] Univ Bristol, Bristol BS6 6JL, Avon, England
[4] United Bristol Healthcare Trust, Milne Ctr, Bristol BS2 8HW, Avon, England
[5] Publ Hlth Lab Serv, Bristol Lab, Bristol BS2 8EL, Avon, England
[6] Publ Hlth Lab Serv, Birmingham Lab, Birmingham B9 5ST, W Midlands, England
[7] Univ Birmingham, Hlth Serv Management Ctr, Birmingham B15 2RT, W Midlands, England
[8] Heart Birmingham Primary Care Trust, Whittall St Clin, Birmingham B4 6DH, W Midlands, England
关键词
D O I
10.1136/sti.2003.006197
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Screening has been recommended to reduce the prevalence and morbidity associated with genital chlamydia infection in the United Kingdom. Methods: We describe the rationale and study design of the Chlamydia Screening Studies (ClaSS), a collaborative project designed to evaluate screening outside genitourinary medicine clinics. A nonselective, active screening approach in 16-39 year olds randomly sampled from 27 general practice lists in the Bristol and Birmingham areas formed the basis of interlinked studies: a case-control study was used to investigate factors to improve the targeting of screening; participants with chlamydia were invited to enrol in a randomised controlled trial to evaluate partner notification conducted in primary care; and laboratory based studies were used to assess the best specimens and tests. We also explored psychosocial effects of screening and partner notification and modelled the cost effectiveness of the programme. Conclusion: Results from four pilot practices show that mailing of specimens for chlamydia testing is feasible but that it is difficult to achieve high response rates with postal screening. The high prevalence of asymptomatic infection in men suggests that efforts to screen men for chlamydia should be strengthened.
引用
收藏
页码:342 / 348
页数:7
相关论文
共 50 条
  • [41] Thermodynamic studies for drug design and screening
    Garbett, Nichola C.
    Chaires, Jonathan B.
    EXPERT OPINION ON DRUG DISCOVERY, 2012, 7 (04) : 299 - 314
  • [42] Screening design for model sensitivity studies
    Welsh, JP
    Koenig, GG
    Bruce, D
    JOURNAL OF GEOPHYSICAL RESEARCH-ATMOSPHERES, 1997, 102 (D14) : 16499 - 16505
  • [43] RATIONALE AND DESIGN
    BORHANI, NO
    APPLEGATE, WB
    CUTLER, JA
    DAVIS, BR
    FURBERG, CD
    LAKATOS, E
    PAGE, L
    PERRY, HM
    SMITH, WM
    PROBSTFIELD, JL
    HYPERTENSION, 1991, 17 (03) : 2 - 15
  • [44] Randomized clinical trials for cancer screening: Rationale and design considerations for imaging tests
    Black, William C.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (20) : 3252 - 3260
  • [45] The NordICC Study: Rationale and design of a randomized trial on colonoscopy screening for colorectal cancer
    Kaminski, M. F.
    Bretthauer, M.
    Zauber, A. G.
    Kuipers, E. J.
    Adami, H. -O.
    van Ballegooijen, M.
    Regula, J.
    van Leerdam, M.
    Stefansson, T.
    Paehlman, L.
    Dekker, E.
    Hernan, M. A.
    Garborg, K.
    Hoff, G.
    ENDOSCOPY, 2012, 44 (07) : 695 - 702
  • [46] The mental health screening of conscripts for the Singapore armed forces: Rationale, objectives, and design
    Chong, Siow-Ann
    Wong, John
    Verma, Swapna
    Subramaniam, Mythily
    Pek, Elaine
    Chan, Yiong Huak
    Lee, I-Min
    Cheok, Christopher
    MILITARY MEDICINE, 2007, 172 (12) : 1245 - 1249
  • [47] Rationale and design of the screening of pulmonary hypertension in systemic lupus erythematosus (SOPHIE) study
    Huang, Duo
    Cheng, Yang-Yang
    Chan, Pak-Hei
    Hai, Jojo
    Yiu, Kai-Hang
    Tse, Hung-Fat
    Wong, Ka-Lam
    Fan, Katherine
    Li, Ying Wah
    Ng, Woon-Leung
    Yim, Cheuk-Wan
    Wong, Cheuk-Hon John
    Tam, Lai-Shan
    Wong, Priscilla C. H.
    Wong, Chi-Yuen
    Ho, Chup-Hei
    Leung, Alexander M. H.
    Mok, Chi-Chiu
    Lam, Ho
    Lau, Chak-Sing
    Cheung, Tommy
    Ho, Carmen
    Law, Sharon W. Y.
    Chan, Esther W.
    Yin, Li-Xue
    Yue, Wen-Sheng
    Mok, Toi Meng
    Evora, Mario Alberto
    Siu, Chung-Wah
    ERJ OPEN RESEARCH, 2018, 4 (01)
  • [48] Chlamydia screening programme extension
    Wakley, G
    JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2004, 30 (02): : 132 - 132
  • [49] SCREENING FOR CHLAMYDIA INFECTION - REPLY
    BLACKWELL, AL
    THOMAS, PD
    WAREHAM, K
    EMERY, SJ
    LANCET, 1993, 342 (8872): : 688 - 689
  • [50] Advances in sampling and screening for chlamydia
    Hocking, Jane S.
    Guy, Rebecca
    Walker, Jennifer
    Tabrizi, Sepehr N.
    FUTURE MICROBIOLOGY, 2013, 8 (03) : 367 - 386